A Meta-analysis of the Use of Polypill for Secondary Prevention of Atherosclerotic Cardiovascular Disease
Department
Internal Medicine
Document Type
Article
Publication Title
American Journal of Therapeutics
First Page
e193
Last Page
e195
DOI
10.1097/MJT.0000000000001583
Volume
31
Issue
2
Publication Date
3-1-2024
Publisher
Lippincott Williams & Wilkins
Medical Subject Headings
Humans; Cardiovascular Diseases; Secondary Prevention; Cardiovascular Agents; Atorvastatin; Drug Combinations; Antihypertensive Agents; Hydroxymethylglutaryl-CoA Reductase Inhibitors
PubMed ID
36857708
Recommended Citation
Al-Abdouh, A., Mhanna, M., Jabri, A., Ahmed, T., Altibi, A. M., Ghanem, F., Alhuneafat, L., Zaalouk, M., Abusnina, W., Dewaswala, N., Bhopalwala, H., Kundu, A., & Michos, E. D. (2024). A Meta-analysis of the Use of Polypill for Secondary Prevention of Atherosclerotic Cardiovascular Disease. American Journal of Therapeutics, 31 (2), e193-e195. https://doi.org/10.1097/MJT.0000000000001583